Josh Fischman

The Nobel Prize in Chemistry goes to biochemist David Baker, and Google DeepMind scientists Demis Hassabis and John Jumper, for predicting protein shapes and functions— and for creating entirely new ones that can improve health and the environment

The deadly virus was practically eliminated in the U.S., but now it’s infecting more people.

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, long dismissed by doctors, causes immune system dysfunction and other problems. But treatments are lacking.

Nose-plus-throat swabbing for COVID could increase test accuracy—but could create problems, too

A noninvasive test for genetic material could predict embryo quality in IVF.

The holidays are a time for indulgence, but there are ways to drink alcohol without suffering the painful effects.

Problems with the heart, kidneys and metabolic health are all connected

Problems with the heart, kidneys and metabolic health are all connected

Fewer kids got their routine childhood vaccines since before the pandemic. Are lack of access and a loss of trust in science to blame?

More than half of our diet is foods that have been industrially processed in some way, and it may be harmful to our health

The dangerous virus is still here. Here’s how you can stay safe.

The popular decongestant phenylephrine is not effective, an FDA panel found. Here’s what to use instead.

Three scientists won the Nobel in Chemistry for their discovery of quantum dots, an entirely new class of material used in large-screen TVs and cancer surgery

In inflammatory bowel disease, mental stress can produce two painful responses

Hearing aids may help maintain better brain functions in older people and better health overall.

Drugs such as Wegovy and Ozempic might help people tackle substance abuse as well as shed pounds.

The party drug MDMA could soon be approved for treating people with severe PTSD.

Post-COVID symptoms can linger for months or years, and more and more evidence points to problems with the nervous system.

A vaccine pioneer tells us that shots to protect against RSV—a dangerous virus for babies and older people—are finally nearing approval.

Vaccines saved New York City billions of dollars, and China faces public fury over its strict virus-control policies.